Mucin synthesis inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 18, 2008
Grant Date -
Dec 25, 2003
app pub date -
Nov 8, 2002
filing date -
Jan 31, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds of Formula II in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases. ##STR00001## wherein X is S, N, O or CR; Y is CRR', O, NR.sub.6, CRR'--CRR' or CR.dbd.CR; Z is NR.sub.6, O, S, CRR' or CRR'--CRR'; R.sub.1-R.sub.3 are independently selected from the group consisting of H, C.sub.1-C.sub.8 alkyl, C.sub.1-C.sub.8 alkoxy, amino, hydroxy, halosubstituted alky and halo; R.sub.4 is ##STR00002## ##STR00003## Q is CR, NR.sub.6 or ##STR00004## R.sub.5 is H or benzyl; R.sub.6 is H, C.sub.1-C.sub.8 alkyl, C.sub.1-C.sub.8 alkoxy, OH or halo; and R and R' are independently H, C.sub.1-C.sub.8 alkyl, C.sub.1-C.sub.8 alkoxy, OH or halo, or a pharmaceutically acceptable salt thereof.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully